Exploring the Impact of Open Source Software on the Pharmaceutical Industry with Katja Glass

Transformation in Trials

Prepare to uncover the transformative potential of open source software in the pharmaceutical industry! Our distinguished guest, Katja Glass, an influential open source ambassador, joins us on this enlightening journey. We'll explore the rising popularity of open source solutions in the pharmaceutical industry, its myriad benefits, and the profound impact of sharing tools, processes, and software.
Turn up the volume as we unravel the advantageous features of the Open Study Builder. This unique tool has not only helped pharma companies in embracing automation but also presents an innovative approach towards modern metadata repositories. We take a closer look at how its properties facilitate creating protocols, bringing a refreshing twist to the traditional processes.
As we conclude, we ponder over the future prospects of the Open Study Builder, the implications and the exciting opportunities for tech vendors to engage with the Open Study Builder ecosystem. Katja shares her perspectives on the possible transformations. Tune in as we draw parallels between the pharmaceutical industry and other sectors and explore what lessons can be learned from their uptake of open source. So, buckle up and get ready for an intriguing conversation revolving around the changing dynamics of trials in the pharma industry!
Guest:
Katja Glass

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

Hoofdstukken

1. Exploring the Impact of Open Source Software on the Pharmaceutical Industry with Katja Glass (00:00:00)

2. Open Source Software in Pharma Industry (00:00:13)

3. Benefits of Open Source Study Builder (00:11:50)

4. Future of Open Study Builder (00:21:23)

5. Open Study Builder Discussion With Katja (00:33:45)